The recognised starting point
ACi and MACi
The established search terms for cell-based cartilage regeneration. Professor Lee uses them as the familiar reference point when explaining the newer non-surgical and surgical pathways.
International patients · Oman
Cartilage and regenerative orthopaedic treatment in London for Omani patients
Patients from Muscat and across Oman travel to London for ACi and MACi assessment, the Nano RegenRepair™ family, surgical STACi, ChondroFiller and Mytocel MSK with Professor Paul Lee.
Read the International Patient Guide
Reviewed byProfessor Paul Lee MBBch, FRCS (Tr & Orth), PhDCartilage and joint preservation expertiseWhy London Cartilage Clinic
A direct, specialist pathway from Muscat to Harley Street
Muscat has a direct London link and Omani patients are part of the well-established flow of Arabian Peninsula patients using UK private healthcare. London Cartilage Clinic makes that journey clinically purposeful by reviewing scans first and keeping the assessment, treatment and early follow-up with Professor Paul Lee.
The familiar ACi and MACi terms provide the starting point. The full assessment then introduces the non-surgical Nano pathways, STACi when Structure needs surgery, ChondroFiller as a collagen scaffold treatment and Mytocel MSK as a standalone autologous micrograft injection.
Searching for “علاج الركبة في لندن”?That is us, knee treatment in London.
Why patients travel for treatment
Start with ACi or MACi. Then see what is now possible.
Patients from Oman often arrive searching for ACi or MACi because those are the best-known cartilage cell treatments. They remain important. The assessment also shows where NanoACi, the wider Nano family, the Structure-led STACi pathway, ChondroFiller or Mytocel MSK may fit more precisely.
Non-surgical RegenRepair™
The Nano family
NanoACi for cartilage, NanoAMi for meniscus, NanoATi for tendon and NanoALi for ligament adapt Seed, Soil and Signal to the tissue being treated.
Surgical RegenRepair™
STACi adds Structure
When alignment, stability or the damage pattern needs surgery, STACi addresses Structure before adding the Seed, Soil and Signal cartilage-regeneration biology.
Standalone or within a pathway
Mytocel MSK and ChondroFiller
Mytocel MSK provides living autologous micrografts; ChondroFiller provides a collagen scaffold. Each has a standalone role and both sit within Professor Lee’s wider regenerative toolkit.
Been told replacement is your only option?
Have you been advised to replace the joint in Oman?
Professor Lee assesses whether the joint still has a realistic preservation route by looking at the cartilage damage and the mechanics around it. No single regenerative treatment suits every stage of arthritis.
Where damage can support a non-arthroscopic route, NanoACi may be considered. Where alignment, instability or the defect needs surgical treatment, STACi adds Structure before the regenerative components. Replacement remains the honest recommendation where preservation is no longer appropriate.
Every alternative-to-replacement statement is a clinical judgement made only after a full assessment. Suitability depends on your individual case.
Most relevant treatments
Treatments most relevant to patients from Oman
ACi and MACi
The better-known cell-based cartilage regeneration procedures, kept as a clear starting point and assessed alongside NanoACi and the Structure-led STACi pathway.
Find out more
RegenRepair™ and the Nano family
Professor Lee’s Seed, Soil, Signal framework, adapted into NanoACi for cartilage, NanoAMi for meniscus, NanoATi for tendon and NanoALi for ligament.
Find out more
NanoACi
A non-arthroscopic cartilage-regeneration pathway combining autologous micrografts, a collagen scaffold and platelet-rich fibrin in one image-guided session.
Find out more
STACi
Professor Lee’s surgical RegenRepair™ pathway: Structure first, then Seed, Soil and Signal for cartilage damage that needs mechanical correction or stabilisation as well as regeneration.
Find out more
ChondroFiller
Collagen cartilage regeneration delivered by injection, made by Meidrix Biomedicals GmbH. The clinic was the first in the UK to offer it as an injection.
Find out more
Mytocel MSK
A single-session regenerative injection using living autologous micrografts prepared chair-side from a small sample of the patient’s own tissue.
Find out moreGetting here
Getting here from Oman
Direct Muscat–London services make one planned treatment visit possible. A virtual assessment and imaging review reduce uncertainty before the patient leaves Oman.
Direct from Muscat
Muscat connects directly with London Heathrow. Current timings vary, so the treatment window is built around the confirmed itinerary.
Virtual-first assessment
Professor Lee can review the history and available imaging before recommending an in-person examination or treatment visit.
Plan mobility before flying
The return plan considers the procedure, walking ability, journey length and personal blood-clot risk.
Visiting us
How to find us
Consultations
66 Harley Street
London W1G 7HD
United Kingdom
Surgery
A partner hospital on Weymouth Street, a few minutes from Harley Street. Imaging is arranged for you as part of your pathway.
Getting here
Central London, a short walk from Regent’s Park, Oxford Circus and Bond Street underground stations.
Costs and insurance
Costs and insurance for patients from Oman
Omani rials (OMR)direct pay or prior written funding approval
Treatment is quoted in pounds sterling, with currency conversion from Omani rials handled by the patient’s bank or card provider. A treatment-specific estimate is issued after assessment.
Any insurer, employer or public sponsor must confirm eligibility and payment arrangements in writing. Clinical acceptance does not imply funding approval. Without prior authorisation the treatment is direct pay.
Authority
The surgeon you are choosing
International patients are usually choosing between a small number of world specialists, so the surgeon matters more than any single treatment. Your consultation, your treatment and your follow-up are all with Professor Paul Lee.
- Consultant Orthopaedic Surgeon and medical engineer, PhD
- Internationally published in cartilage repair and joint preservation, cited over 1,000 times
- Lead of an ICRS teaching centre for cartilage regeneration
- Joint-replacement outcomes recorded in the National Joint Registry, within the expected range
- Member of the British Association for Surgery of the Knee (BASK)
International patients · Oman
Frequently asked questions
Do Omani patients need to travel for the first consultation?
Not usually. A discovery call can be followed by a virtual consultation with Professor Lee, with available MRI images reviewed in advance. Travel is planned once there is a clear reason for an in-person assessment or treatment.
Which regenerative treatments are available in London?
The clinic assesses ACi and MACi alongside NanoACi, NanoAMi, NanoATi, NanoALi, STACi, ChondroFiller and Mytocel MSK. These are not interchangeable; the right route depends on the damaged tissue, joint mechanics and stage of disease.
Can follow-up continue in Oman?
Early review is completed in London when required. Later imaging, rehabilitation and clinical updates can be coordinated with clinicians in Oman, with Professor Lee available for remote review.
How is a return flight after treatment planned?
There is no universal waiting period. The team considers treatment type, mobility, flight duration, wound healing where applicable and personal blood-clot risk before clinical clearance is considered.
Start your journey from Oman
Wherever you are travelling from, the first step is the same. Talk it through on a discovery call, or have a virtual consultation with Professor Lee before you plan any travel.